300 related articles for article (PubMed ID: 34169440)
1. Precision Medicine in the Treatment of Primary Immune Deficiency Patients With Disorders of Immune Dysregulation.
Ballow M; Leiding JW
Clin Rev Allergy Immunol; 2022 Aug; 63(1):1-8. PubMed ID: 34169440
[TBL] [Abstract][Full Text] [Related]
2. Precision medicine in the treatment of primary immunodeficiency diseases.
Leiding JW; Ballow M
Curr Opin Allergy Clin Immunol; 2018 Apr; 18(2):159-166. PubMed ID: 29406361
[TBL] [Abstract][Full Text] [Related]
3. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity.
Maccari ME; Wolkewitz M; Schwab C; Lorenzini T; Leiding JW; Aladjdi N; Abolhassani H; Abou-Chahla W; Aiuti A; Azarnoush S; Baris S; Barlogis V; Barzaghi F; Baumann U; Bloomfield M; Bohynikova N; Bodet D; Boutboul D; Bucciol G; Buckland MS; Burns SO; Cancrini C; Cathébras P; Cavazzana M; Cheminant M; Chinello M; Ciznar P; Coulter TI; D'Aveni M; Ekwall O; Eric Z; Eren E; Fasth A; Frange P; Fournier B; Garcia-Prat M; Gardembas M; Geier C; Ghosh S; Goda V; Hammarström L; Hauck F; Heeg M; Heropolitanska-Pliszka E; Hilfanova A; Jolles S; Karakoc-Aydiner E; Kindle GR; Kiykim A; Klemann C; Koletsi P; Koltan S; Kondratenko I; Körholz J; Krüger R; Jeziorski E; Levy R; Le Guenno G; Lefevre G; Lougaris V; Marzollo A; Mahlaoui N; Malphettes M; Meinhardt A; Merlin E; Meyts I; Milota T; Moreira F; Moshous D; Mukhina A; Neth O; Neubert J; Neven B; Nieters A; Nove-Josserand R; Oksenhendler E; Ozen A; Olbrich P; Perlat A; Pac M; Schmid JP; Pacillo L; Parra-Martinez A; Paschenko O; Pellier I; Sefer AP; Plebani A; Plantaz D; Prader S; Raffray L; Ritterbusch H; Riviere JG; Rivalta B; Rusch S; Sakovich I; Savic S; Scheible R; Schleinitz N; Schuetz C; Schulz A; Sediva A; Semeraro M; Sharapova SO; Shcherbina A; Slatter MA; Sogkas G; Soler-Palacin P; Speckmann C; Stephan JL; Suarez F; Tommasini A; Trück J; Uhlmann A; van Aerde KJ; van Montfrans J; von Bernuth H; Warnatz K; Williams T; Worth AJJ; Ip W; Picard C; Catherinot E; Nademi Z; Grimbacher B; Forbes Satter LR; Kracker S; Chandra A; Condliffe AM; Ehl S;
J Allergy Clin Immunol; 2023 Oct; 152(4):984-996.e10. PubMed ID: 37390899
[TBL] [Abstract][Full Text] [Related]
4. Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.
Zhang W; Chen X; Gao G; Xing S; Zhou L; Tang X; Zhao X; An Y
Front Immunol; 2021; 12():654406. PubMed ID: 33777053
[No Abstract] [Full Text] [Related]
5. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.
López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM
Front Immunol; 2021; 12():671755. PubMed ID: 34447369
[TBL] [Abstract][Full Text] [Related]
6. Precision Therapy for the Treatment of Primary Immunodysregulatory Diseases.
Chellapandian D; Chitty-Lopez M; Leiding JW
Immunol Allergy Clin North Am; 2020 Aug; 40(3):511-526. PubMed ID: 32654696
[TBL] [Abstract][Full Text] [Related]
7. Molecular requirements for human lymphopoiesis as defined by inborn errors of immunity.
Della Mina E; Guérin A; Tangye SG
Stem Cells; 2021 Apr; 39(4):389-402. PubMed ID: 33400834
[TBL] [Abstract][Full Text] [Related]
8. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.
Fischer M; Olbrich P; Hadjadj J; Aumann V; Bakhtiar S; Barlogis V; von Bismarck P; Bloomfield M; Booth C; Buddingh EP; Cagdas D; Castelle M; Chan AY; Chandrakasan S; Chetty K; Cougoul P; Crickx E; Dara J; Deyà-Martínez A; Farmand S; Formankova R; Gennery AR; Gonzalez-Granado LI; Hagin D; Hanitsch LG; Hanzlikovà J; Hauck F; Ivorra-Cortés J; Kisand K; Kiykim A; Körholz J; Leahy TR; van Montfrans J; Nademi Z; Nelken B; Parikh S; Plado S; Ramakers J; Redlich A; Rieux-Laucat F; Rivière JG; Rodina Y; Júnior PR; Salou S; Schuetz C; Shcherbina A; Slatter MA; Touzot F; Unal E; Lankester AC; Burns S; Seppänen MRJ; Neth O; Albert MH; Ehl S; Neven B; Speckmann C
J Allergy Clin Immunol; 2024 Jan; 153(1):275-286.e18. PubMed ID: 37935260
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Yield and Therapeutic Consequences of Targeted Next-Generation Sequencing in Sporadic Primary Immunodeficiency.
Sogkas G; Dubrowinskaja N; Schütz K; Steinbrück L; Götting J; Schwerk N; Baumann U; Grimbacher B; Witte T; Schmidt RE; Atschekzei F
Int Arch Allergy Immunol; 2022; 183(3):337-349. PubMed ID: 34619682
[TBL] [Abstract][Full Text] [Related]
10. Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency.
Cepika AM; Sato Y; Liu JM; Uyeda MJ; Bacchetta R; Roncarolo MG
J Allergy Clin Immunol; 2018 Dec; 142(6):1679-1695. PubMed ID: 30527062
[TBL] [Abstract][Full Text] [Related]
11. Inborn Errors of Immunity With Immune Dysregulation: From Bench to Bedside.
Delmonte OM; Castagnoli R; Calzoni E; Notarangelo LD
Front Pediatr; 2019; 7():353. PubMed ID: 31508401
[TBL] [Abstract][Full Text] [Related]
12. The Immune Deficiency and Dysregulation Activity (IDDA2.1 'Kaleidoscope') Score and Other Clinical Measures in Inborn Errors of Immunity.
Seidel MG; Tesch VK; Yang L; Hauck F; Horn AL; Smolle MA; Quehenberger F; Benesch M
J Clin Immunol; 2022 Apr; 42(3):484-498. PubMed ID: 34797428
[TBL] [Abstract][Full Text] [Related]
13. ANCA vasculitis expands the spectrum of autoimmune manifestations of activated PI3 kinase δ syndrome.
Sood AK; Francis O; Schworer SA; Johnson SM; Smith BD; Googe PB; Wu EY
Front Pediatr; 2023; 11():1179788. PubMed ID: 37274825
[TBL] [Abstract][Full Text] [Related]
14. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Vargas-Hernández A; Mace EM; Zimmerman O; Zerbe CS; Freeman AF; Rosenzweig S; Leiding JW; Torgerson T; Altman MC; Schussler E; Cunningham-Rundles C; Chinn IK; Carisey AF; Hanson IC; Rider NL; Holland SM; Orange JS; Forbes LR
J Allergy Clin Immunol; 2018 Jun; 141(6):2142-2155.e5. PubMed ID: 29111217
[TBL] [Abstract][Full Text] [Related]
15. Updates on new monogenic inborn errors of immunity.
Castagnoli R; Notarangelo LD
Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26(Suppl 26):57-59. PubMed ID: 33236415
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 3-kinase signaling and immune regulation: insights into disease pathogenesis and clinical implications.
Nguyen T; Deenick EK; Tangye SG
Expert Rev Clin Immunol; 2021 Aug; 17(8):905-914. PubMed ID: 34157234
[TBL] [Abstract][Full Text] [Related]
17. Immunodeficiency and disorders of immune dysregulation.
Delmonte OM
Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():8-10. PubMed ID: 32017223
[TBL] [Abstract][Full Text] [Related]
18. Signal transducer and activator of transcription gain-of-function primary immunodeficiency/immunodysregulation disorders.
Consonni F; Dotta L; Todaro F; Vairo D; Badolato R
Curr Opin Pediatr; 2017 Dec; 29(6):711-717. PubMed ID: 28914637
[TBL] [Abstract][Full Text] [Related]
19. Inborn Errors of Immunity and Autoimmune Disease.
Gray PE; David C
J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1602-1622. PubMed ID: 37119983
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results From a Prospective Study.
Schiavo E; Martini B; Attardi E; Consonni F; Ciullini Mannurita S; Coniglio ML; Tellini M; Chiocca E; Fotzi I; Luti L; D'Alba I; Veltroni M; Favre C; Gambineri E
Front Immunol; 2021; 12():790455. PubMed ID: 35058929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
